Stress, Pyridostigmine and the Blood Brain Barrier

  • E. Grauer


Pyridostigmine is a carbamate acetylcholinesterase (AChE) inhibitor that does not readily enter the brain. It is used clinically in the treatment of myastenia gravis (Tylor, 1990), and as part of the treatment against nerve agents poisoning. In the latter, pyridostigmine is used as a pre-treatment, effective only in combination with an immediate post exposure administration of anticholinergic drugs and an oxime reactivator. It was widely used during the Gulf war as a pre-treatment against possible chemical warfare attack (Keeler et al.,1991) and following continuous reports of long-term illness in Gulf war veterans, was suspected to contribute to the illness termed “the Gulf War syndrome” (Blanck et al.,1995, Haley et al.,1997a-c, The Iowa Persian Gulf study group, 1997, Nisenbaum et al.,2000). However, the syndrome includes symptoms attributed to central nervous system (CNS) dysfunction (e.g. impaired cognition, fatigue, sleep disturbance, confusion), which could not be easily explained by the effects of a compound that does not enter the CNS. The controversy around the “Gulf war syndrome” was further complicated by the suggestion that stress exposure (physical conditions, combat related anxiety, perceived threat from biological or chemical weapons) may account for most of the long-term effects reported by the veterans (David et al.,1997, Hyams et al,1996, Ismail et al.,1999, Nisenbaum et al.,2000, but see also Haley et al.,1997).


West Nile Virus Stress Exposure Plasma Corticosterone Level Stressed Mouse Pyridostigmine Bromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alonso S.J., Navarro E., Santana C., Rodriguez M, (1997), Motor lateralization, behavioral despair and dopaminergic brain asymmetry after prenatal stress. Pharmacol. Biochem. Behav., 58(2): 443–448.PubMedCrossRefGoogle Scholar
  2. Ashani, Y., Catravas, G.N. and Alter, W.A., 1981, An irreversible anticholinesterase probe for studying increased permeability of the rat blood-brain barrier. Biochemical Pharmacology, 30(18): 2585–2592.PubMedCrossRefGoogle Scholar
  3. Belova, T.I. and Jonsson, G., 1982, Blood-brain barrier permeability and immobilization stress. Acta Physiol. Scand., 116: 21–29.PubMedCrossRefGoogle Scholar
  4. Ben-Nathan, D., Lustig, S. and Feuerstein, G., 1989, The influence of cold or isolation stress on neuroinvasivness and neurovirulance of an attenuated variant of West Nile virus. Arch. Virol, 109: 1–10.PubMedCrossRefGoogle Scholar
  5. Blanck, R.R., Hiatt, J., Hymas, K.C., Kang, H., Mather, S., Murphy, F., Roswell, R. & Tacker, S.B., 1995, Unexplained illness among desert storm veterans. Arch. Int. Med. 155: 262–268.CrossRefGoogle Scholar
  6. Dallaire, L., Tremblay, L. and Beliveau, R., 1991, Purification and characterization of metabolically active capillaries of the blood-brain barrier. Biochem. J., 276(3): 745–752.PubMedGoogle Scholar
  7. David, A., Ferry, S. and Wessely, S., 1997, Gulf war illness. British Med. J., 314: 239–240.CrossRefGoogle Scholar
  8. Fride E., Weinstock M, 1988, Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci., 42(10): 1059–1065.PubMedCrossRefGoogle Scholar
  9. Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H. and Tur-Kaspa, I., 1996, Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Medicine, 2(12): 1382–1385.PubMedCrossRefGoogle Scholar
  10. Glickson., M., et al., 1991, The influence of pyridostigmine on human neuromuscular functions — studies in healthy human subjects. Foundam. Appl. Toxicol., 16: 288–298.CrossRefGoogle Scholar
  11. Grauer, E., Ben-Nathan, D., Lustig, S., Kapon, J. and Danenberg H.D., 2001, Viral Neuroinvasion as a marker for BBB integrity following exposure to Cholinesterase inhibitors. Life Sciences, 68(9), 985–990.PubMedCrossRefGoogle Scholar
  12. Grauer, E., Alkalai, D., Kapn, J., Cohen, G., Raveh, L., 2000, Stress does not enable pyridostigmine to inhibit brain Cholinesterase after parenteral administration. Tox. Appl. Pharmacol. 164: 301–304.Google Scholar
  13. Haley, R.W., 1997, Is the Gulf war syndrome due to stress? The evidence reexamined. American J. Epidemiology, 146(9), 695–703.CrossRefGoogle Scholar
  14. Haley, R.W., Horn, J. et al., 1997a, Evaluation of neurological function in Gulf War veterans: A blinded case control study. JAMA, 277(3): 223–230.PubMedCrossRefGoogle Scholar
  15. Haley, R.W., Kurt, T.L. & Horn, J., 1997b, Is there a gulf war syndrome? Searching for syndromes by factor analysis of symptoms. JAMA, 277(3): 215–222.PubMedCrossRefGoogle Scholar
  16. Haley, R.W., Kurt, T.L. & Horn, J., 1997c, Self-reported exposure to neurotoxic chemical combinations in the Gulf War. JAMA, 277(3): 231–237.PubMedCrossRefGoogle Scholar
  17. Haley RW, Fleckenstein JL, Marshall WW, McDonald GG, Kramer GL, Petty F., 2000, Effect of basal ganglia injury on central dopamine activity in Gulf War syndrome: correlation of proton magnetic resonance spectroscopy and plasma homovanillic acid levels. Arch Neurol., 57(9): 1280–1285.PubMedCrossRefGoogle Scholar
  18. Haley RW, Marshall WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL., 2000, Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology. 215(3): 807–817.PubMedGoogle Scholar
  19. Houser V.P., 1976, Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat. Pharmacol. Biochem. Behav. 4(5): 561–568.PubMedCrossRefGoogle Scholar
  20. Hyams, K.C., Wignall, F.S. and Roswell, R., 1996, War syndromes and their evaluation: from the U.S. Civil war to the Persian Gulf War. Annals of International Medicine, 125(5): 398–405.Google Scholar
  21. Ismail, K., Everitt, B., Blatchley, N., Hull, L., Unwin, C., David, A., Wessely, S., 1999, Is there a Gulf war syndrome? Lancet, 353: 179–182.PubMedCrossRefGoogle Scholar
  22. Janowsky, D.S., Risch, S.C., Kennedy, B. and Ziegler, M.G., 1986, Acute effects of physostigmine and neostigmine in man. Military Medicine. 151: 48–51.PubMedGoogle Scholar
  23. Joo, F. and Csillik, B., 1966, Topographic correlation between the hemato-encephalic barrier and the Cholinesterase activity of brain capillaries. Exp. Brain Res., 1: 147–151.PubMedCrossRefGoogle Scholar
  24. Joo, F. and Varkonyi, T., 1969, Correlataion between the Cholinesterase activity of capillaries and the blood-brain barrier in the rat. Acta. Biol. Acad. Sci. Hung. 20(4): 359–372.PubMedGoogle Scholar
  25. Keeler J.R., Hurst C.G., Dunn M.A., 1991, Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 266(5): 693–695.PubMedCrossRefGoogle Scholar
  26. Lallement, G., Foquin, A., Baubuchon, D., Burckhart, M.F., Carpentier, D. and Canini F., 1998, Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea-pigs. NeuroToxicology. 19(6): 759–766.PubMedGoogle Scholar
  27. Nisenbaum, R., Barrett, D.H., Reyes, M., and Reeves, W.C. 2000, Deployment Stressors and a chronic multisymptom illness among Gulf war veterans. The J. Nerv. Mental Disease 188(5): 259–266.CrossRefGoogle Scholar
  28. Pelton, G.H., Lee, Y., Davis, M., 1997, Repeated stress, like Vasopressin, sensitizes the excitatory effects of corticotropine releasing factor on the acoustic startle reflex. Brain Res., 778(2): 381–387.PubMedCrossRefGoogle Scholar
  29. Petrali, J.P., Maxwell, D.M., Leite, D.E. and Mills, K.R., 1991, Effect on an anticholinesterase compound on the ultrastructure and function of the blood-brain barrier: a review and experiment. J. Submicrosc. Cytol. Pathol., 23(2): 331–338.PubMedGoogle Scholar
  30. Raven L., Chapman S., Cohen G., Alkalay D., Gilat E., Rabinovitz I., Weissman B.A., 1999, The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology, 20(4): 551–559.Google Scholar
  31. Rodriguez M., Santana C., Afonso D., 1994, Maternal ingestion of tyrosine during rat pregnancy modifies the offspring behavioral lateralization. Physiol. Behav., 55(4): 607–613.PubMedCrossRefGoogle Scholar
  32. Sellstrom, A., Algers, G. and Karlsson, B., 1985, Soman intoxication and the blood-brain barrier. Fundam. Appl. Toxicol, 5(6 pt2): S122–S126.PubMedCrossRefGoogle Scholar
  33. Servatius, R.J., Ottenweller, J.E., Beldowitz, D., Guo, W., Zhu, G.P., Natelson, B.H. 1998, Exaggerated startle responses in rats treated with pyridostigmine bromide. J. Pharmacol. Exp.Ther, 287: 1020–1028.PubMedGoogle Scholar
  34. Servatius, R.J., Ottenweller, J.E., Guo, W., Beldowitz, D., Zhu, G.P., Natelson, B.H. 2000, Effects of inescapable stress and treatment with pyridostigmine bromide on plasma buturylcholynesterase and the acoustic startle response. Physiology and behavior, 69: 239–246.PubMedCrossRefGoogle Scholar
  35. Sharabi, Y., Danon, Y.L. Berkenstadt, H., Almog, S., Mimouni-Bloch, A., Zisman, A., Dani, S. and Atsmon, J., 1991, Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Israel J. Med. Sci., 27: 656–658.PubMedGoogle Scholar
  36. Sharma, H.S. and Dey, P.K., 1986, Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology, 25(2): 161–167.PubMedCrossRefGoogle Scholar
  37. Sharma, H.S. and Dey, P.K., 1988, EEG changes following increased blood-brain barrier permeability under long-term immobilization stress in young rats. Neuroscience Res., 5: 224–239.CrossRefGoogle Scholar
  38. Sharma, H.S., Cervos-Navarro, J., Dey, P.K., 1991, Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10: 211–221.PubMedCrossRefGoogle Scholar
  39. Sinton, C.M., Fitch, T.E., Petty, F., Haley, R.W., 2000, Stressful manipulations that elevate corticosterone reduce blood brain barrier permeability to pyridostigmine in the rat. Tox. Appl. Pharmacol., 165: 99–105.CrossRefGoogle Scholar
  40. Skultetyova, I., Tokarev, D. and Jezova, D., 1998, Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats. Brain Res. Bull., 45(2): 175–178.PubMedCrossRefGoogle Scholar
  41. Trojan D.A., Collet J.P., Shapiro S., Jubelt B., Miller R.G., Agre J.C., Munsat T.L., Hollander D., Tandan R., Granger C., Robinson A., Finch L., Ducruet T., Cashman NR., 1999, A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology, 53(6): 1225–1233.PubMedCrossRefGoogle Scholar
  42. Telang, F.W., Ding, Y-S., Volkow, N.D., Molina, P.E. and Gatley, S.J., 1999, failure of [11C]-pyridostigmine to cross the blood brain barrier in stressed mice. Nuclear Med. Biol, 26(2): 249–250.CrossRefGoogle Scholar
  43. The Iowa Persian Gulf Study Group. 1997, Self reported Illness and health status among Gulf War veterans: A population-based study. JAMA, 277(3): 238–245.CrossRefGoogle Scholar
  44. Tylor P., 1990, Anticholinesterase agents. In The Pharmacological Basis of Therapeutics, 8th ed. (A.G. Gilman, T.W. Rall, A.S. Nies and P. Tylor, Eds) McGraw Hill, New York, pp. 131–147.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • E. Grauer
    • 1
  1. 1.Department of PharmacologyIsrael Institute for Biological ResearchNess ZionaIsrael

Personalised recommendations